Figure 4 shows that the relative proportion of β2GPI in the reduced form, expressed as a percentage of that observed with the in-house standard, was significantly less in APS patients presenting with vascular thrombosis as compared to healthy controls, autoimmune disease controls, and clinical event controls (all P < 0.0001). The gene discussed is APOH; the disease is autoimmune polyendocrinopathy.